Issue Date: May 16, 2016
Japan’s generics market challenges foreign API makers
Japan is legendary for its focus—many would say obsession—on producing high-quality products. When it comes to sourcing active pharmaceutical ingredients (APIs), Japanese generic drug firms are equally exacting with the requirements that they place on their suppliers.
“We need to custom-manufacture for Japan actives that we already sell in the U.S. and Europe,” said Portia Lin, vice president of marketing and sales at the Taiwanese custom drug manufacturer ScinoPharm, at the CPhI Japan trade show . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society